Skip to main content

Market Overview

Recap: Applied DNA Sciences Q4 Earnings


Shares of Applied DNA Sciences (NASDAQ:APDN) fell 21.15% after the company reported Q4 results.

Quarterly Results

Earnings per share rose 43.06% year over year to ($0.82), which missed the estimate of ($0.52).

Revenue of $314,000 declined by 81.53% year over year, which missed the estimate of $710,000.


Applied DNA Sciences hasn't issued any earnings guidance for the time being.

Applied DNA Sciences hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Dec 17, 2020

Time: 04:30 PM

ET Webcast URL:

Price Action

Company's 52-week high was at $16.39

52-week low: $2.52

Price action over last quarter: down 37.90%

Company Description

Applied DNA Sciences Inc is a provider of DNA-based supply chain, anti-counterfeiting, and anti-theft technology. The company provides its products and services under the brand of SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. It serves clients in various industries including government/military, security and asset marking, industrial parts, pharmaceuticals, textiles and apparel, and printing and packaging. The company has operational footprints across the United States, Europe, Asia, and others.


Related Articles (APDN)

View Comments and Join the Discussion!

Posted-In: Earnings